首页> 中文期刊> 《国际药学研究杂志》 >黄芪配伍丹参治疗心脑血管疾病研究进展

黄芪配伍丹参治疗心脑血管疾病研究进展

         

摘要

Because of the high morbidity and mortality rate,cardio-cerebrovascular diseases,including cerebral embolism, cerebral hemorrhage,cerebral vasospasm and myocardial infarction,have become main diseases threatening human health. Tradition-al chinese medicine(TCM)holds that the basic pathogenesis is Qi imbalances,which could be improved by benefiting Qi and promot-ing blood circulation. The compatibility of Radix astragali and Radix salviae miltiorrhiae are particularly suitable for treating the car-dio-cerebrovascular system diseases by improving Qi deficiency and blood stasis. This paper focuses on the application of Radix astrag-ali,Radix s. miltiorrhiae and their compatibility for treating the cardio-cerebrovascular system diseases. Moreover,our research would offer valuable references for the development of new drugs related to the treatment of cardio-cerebrovascular system diseases.%心脑血管疾病严重威胁人类生命健康,包括脑梗死、脑出血、脑血管痉挛和心肌梗死等,其发病率、致残率和死亡率均较高.中医认为其基本发病机制是气血失衡,可通过益气活血来改善病证.黄芪配伍丹参适宜于气虚血瘀证,可有效改善心脑血管疾病.本文围绕近年来黄芪、丹参及其配伍在治疗心脑血管疾病方面的应用展开论述,为开发新的抗心脑血管疾病用药提供参考依据.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号